| 2010 | 2009
Times Health Columnist Jane Brody interviews SCCA's Dr. Kimberly Allison about her transformative battle with breast cancer
KING 5's Jean Enersen goes to SCCA to find out how the donation procedure for blood marrow donors has changed for the better.
Jean Sather, a Seattle blogger and assertive cancer patient who has helped bring an experimental breast-cancer drug closer to the homes of patients who need it most. SCCA's Dr. Julie Gralow, who is in charge of the trial here, calls Sather "a great example of an educated and informed patient advocate."
Yesterday, the World Health Organization issued a report linking cell phone usage and increased cancer risk. However, in this Q13Fox interview, SCCA's Dr. Marc Chamberlain expresses serious reservations about the research behind the WHO report
Yervoy, the first drug shown to prolong the lives of people with the skin cancer melanoma recently won approval from the FDA. Yervoy is an example of an emerging class of treatments known as immunotherapy that harness the body’s own immune system to fight tumors
Felicia Knaul, a health economist at Harvard Medical School in Boston, doesn't mind telling in detail how breast cancer changed her marriage, her family, and her career. In her mission to shatter taboos around the disease and improve the lives of patients in developing countries, her professional and private lives have become one.
Some women with early breast cancers can safely opt for less surgery, greatly reducing the risk of painful long-term complications, according to a new study that's already changing standard medical practice, including those at SCCA
A blood test so sensitive that it can spot a single cancer cell lurking among a billion healthy ones is moving one step closer to being available at your doctor's office.
| 2010 | 2009